Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,193 | 120 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Teva Pharmaceuticals USA, Inc. | $423.11 | 19 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $392.35 | 18 | $0 (2024) |
| Lilly USA, LLC | $311.82 | 10 | $0 (2024) |
| Novo Nordisk Inc | $303.61 | 11 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $232.10 | 8 | $0 (2024) |
| Inari Medical, Inc. | $228.60 | 3 | $0 (2024) |
| ABBVIE INC. | $193.61 | 8 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $169.29 | 7 | $0 (2024) |
| GlaxoSmithKline, LLC. | $140.42 | 8 | $0 (2024) |
| Axsome Therapeutics, Inc. | $134.15 | 2 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,221 | 55 | AstraZeneca Pharmaceuticals LP ($158.22) |
| 2023 | $1,393 | 44 | Teva Pharmaceuticals USA, Inc. ($292.16) |
| 2022 | $260.01 | 14 | AstraZeneca Pharmaceuticals LP ($88.19) |
| 2021 | $318.35 | 7 | Novo Nordisk Inc ($135.45) |
All Payment Transactions
120 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/06/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $15.40 | General |
| Category: Respiratory | ||||||
| 12/05/2024 | Abbott Laboratories | FREESTYLE LIBRE 2 (Device) | Food and Beverage | In-kind items and services | $20.49 | General |
| Category: Diabetes Care | ||||||
| 11/23/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $22.38 | General |
| Category: NEUROSCIENCE | ||||||
| 11/19/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $24.47 | General |
| Category: PSYCHIATRY | ||||||
| 11/11/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $23.02 | General |
| Category: Diabetes | ||||||
| 11/05/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $18.66 | General |
| Category: NEUROSCIENCE | ||||||
| 11/04/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $13.86 | General |
| Category: Endocrinology | ||||||
| 10/08/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.42 | General |
| Category: RESPIRATORY | ||||||
| 10/04/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $28.48 | General |
| Category: Cardio-renal | ||||||
| 09/24/2024 | Novo Nordisk Inc | Rybelsus (Drug) | Food and Beverage | In-kind items and services | $20.75 | General |
| Category: Diabetes | ||||||
| 08/27/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $25.86 | General |
| Category: NEUROSCIENCE | ||||||
| 08/23/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $24.21 | General |
| Category: Respiratory | ||||||
| 08/20/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $20.08 | General |
| Category: Cardio-renal | ||||||
| 08/12/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $20.17 | General |
| Category: Central Nervous System | ||||||
| 08/12/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.40 | General |
| Category: RESPIRATORY | ||||||
| 08/12/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $2.31 | General |
| Category: Central Nervous System | ||||||
| 07/30/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $75.64 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/17/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $3.91 | General |
| Category: Central Nervous System | ||||||
| 07/11/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $13.16 | General |
| Category: Respiratory | ||||||
| 07/08/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $5.56 | General |
| Category: Central Nervous System | ||||||
| 07/08/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $4.87 | General |
| Category: Central Nervous System | ||||||
| 07/01/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $28.77 | General |
| Category: Diabetes Care | ||||||
| 06/21/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $21.33 | General |
| Category: Diabetes Care | ||||||
| 06/17/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $44.07 | General |
| Category: Central Nervous System | ||||||
| 06/12/2024 | Inari Medical, Inc. | FLOWTRIEVER CATHETER, S (Device), CT THROMBECTOMY SYSTEM KIT | Food and Beverage | In-kind items and services | $17.23 | General |
| Category: VTE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 563 | 879 | $139,920 | $52,216 |
| 2022 | 11 | 313 | 668 | $124,406 | $46,585 |
| 2021 | 6 | 153 | 211 | $35,493 | $16,630 |
All Medicare Procedures & Services
34 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 99 | 266 | $69,160 | $23,930 | 34.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 58 | 58 | $15,126 | $7,292 | 48.2% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 25 | 28 | $15,540 | $6,005 | 38.6% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 18 | 60 | $7,680 | $2,783 | 36.2% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 47 | 47 | $8,037 | $2,616 | 32.5% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 13 | 44 | $4,180 | $1,583 | 37.9% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2023 | 14 | 17 | $4,352 | $1,491 | 34.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 22 | 23 | $4,153 | $1,313 | 31.6% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 58 | 58 | $2,320 | $1,017 | 43.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 77 | 114 | $1,140 | $949.64 | 83.3% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 12 | 12 | $1,721 | $909.72 | 52.9% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 16 | 16 | $2,896 | $896.33 | 31.0% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 31 | 37 | $1,665 | $568.56 | 34.1% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 14 | 36 | $1,080 | $392.38 | 36.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 12 | 12 | $360.00 | $352.80 | 98.0% |
| 81002 | Urinalysis, manual test | Office | 2023 | 14 | 18 | $180.00 | $61.38 | 34.1% |
| 96160 | Administration and interpretation of patient-focused health risk assessment | Office | 2023 | 33 | 33 | $330.00 | $56.64 | 17.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 95 | 313 | $76,490 | $26,939 | 35.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 55 | 55 | $13,374 | $7,108 | 53.1% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2022 | 13 | 18 | $9,355 | $3,891 | 41.6% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2022 | 16 | 75 | $9,555 | $3,500 | 36.6% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2022 | 15 | 73 | $6,966 | $2,641 | 37.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 19 | 19 | $6,460 | $1,772 | 27.4% |
| 99406 | Smoking and tobacco use intensive counseling, 4-10 minutes | Office | 2022 | 12 | 15 | $386.00 | $223.90 | 58.0% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2022 | 14 | 16 | $720.00 | $179.40 | 24.9% |
About Dr. Sam Samarrai, MD
Dr. Sam Samarrai, MD is a Family Medicine healthcare provider based in Temple, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/10/2018. The National Provider Identifier (NPI) number assigned to this provider is 1972000461.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sam Samarrai, MD has received a total of $3,193 in payments from pharmaceutical and medical device companies, with $1,221 received in 2024. These payments were reported across 120 transactions from 22 companies. The most common payment nature is "Food and Beverage" ($3,193).
As a Medicare-enrolled provider, Samarrai has provided services to 1,029 Medicare beneficiaries, totaling 1,758 services with total Medicare billing of $115,431. Data is available for 3 years (2021–2023), covering 34 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Other Specialties Family Medicine
- Location Temple, TX
- Active Since 04/10/2018
- Last Updated 11/12/2025
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1972000461
Products in Payments
- Austedo XR (Drug) $281.64
- FARXIGA (Drug) $273.98
- Kerendia (Drug) $232.10
- FLOWTRIEVER CATHETER, S (Device) $228.60
- MOUNJARO (Drug) $209.32
- VRAYLAR (Drug) $174.95
- REXULTI (Drug) $147.01
- UZEDY (Drug) $141.47
- TRELEGY ELLIPTA (Drug) $140.42
- Auvelity (Drug) $134.15
- RYBELSUS (Drug) $125.00
- NURTEC ODT (Drug) $121.57
- Ozempic (Drug) $103.02
- TRULICITY (Drug) $102.50
- AIRSUPRA (Drug) $97.17
- VOQUEZNA (Drug) $75.64
- Rybelsus (Drug) $75.59
- Dexcom G6 Transmitter (Medical Supply) $67.63
- TRINTELLIX (Drug) $60.24
- FREESTYLE LIBRE 3 (Device) $50.10
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Temple
Dr. Duren Ready, Md, MD
Family Medicine — Payments: $297,807
David Willingham, M.d, M.D
Family Medicine — Payments: $11,118
Dr. Rodney Lange, M.d, M.D
Family Medicine — Payments: $6,502
Dr. Elizabeth Mattson, Md, MD
Family Medicine — Payments: $2,529
Kelsey Pohler, Md, MD
Family Medicine — Payments: $2,444
Dr. Roger Kylberg, Md, MD
Family Medicine — Payments: $1,962